Diabetes Clinical Trials

About DM Clinical Research

DM Clinical Research operates a network of clinical trial sites, functioning as both a site management organization (SMO) and a service provider to sponsors and CROs. Headquartered in Houston with a reported 700+ employees, the company has built an 18+ year track record conducting trials across multiple therapeutic areas. Its business model leverages direct patient recruitment, including an ambassador program, and provides full-service clinical research execution, with a notable involvement in COVID-19 vaccine trials as part of the #HoustonFightsCOVID initiative. The company appears to be a private, revenue-generating services firm in the clinical research sector.

About Diablo Clinical Research

Diablo Clinical Research is a long-established, private clinical research services provider that has recently been integrated into the Flourish Research Network, now operating as Flourish Research – Walnut Creek. With over 1,000 studies completed and a database of more than 18,000 patients, the company leverages deep investigator and staff experience to conduct trials in areas like diabetes, vaccines, weight loss, and medical devices. Its business model is entirely service-based, generating revenue from sponsors and CROs for conducting clinical trials, positioning it as a specialized site within the broader clinical research ecosystem.

Therapeutic Areas

Other Diabetes Drugs